
ISCNF
Healthcare · Drug Manufacturers - Specialty & Generic · $1,759 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 30, 2022 | Time not confirmed | — | -0.02 | — |
| Apr 27, 2022 | After the close | — | -0.00 | — |
| Feb 29, 2020 | Time not confirmed | — | -0.03 | — |
| Nov 30, 2019 | Time not confirmed | — | -0.03 | — |
| Aug 31, 2019 | Time not confirmed | — | -0.02 | — |
| May 31, 2019 | Time not confirmed | — | -0.01 | — |
| Feb 28, 2019 | Time not confirmed | — | -0.02 | — |
| Nov 30, 2018 | Time not confirmed | — | -0.06 | — |
| Aug 31, 2018 | Time not confirmed | — | -0.11 | — |
| May 31, 2018 | Time not confirmed | — | -0.04 | — |
| Feb 28, 2018 | Time not confirmed | — | -0.09 | — |
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.